F8 and hemophilia A: We previously reported that therapeutic levels of plasma FVIII can be successfully achieved in hemophilia A mice by subcutaneous implantation of lentivirally engineered blood outgrowth endothelial cells (BOECs) mixed with Matrigel [9].